Amanote Research
Register
Sign In
De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives
doi 10.1021/acs.jmedchem.9b00454.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4
Scientific Reports
Multidisciplinary
De Novo Biosynthesis of Terminal Alkyne-Labeled Natural Products
Nature Chemical Biology
Cell Biology
Molecular Biology
Direct Capture Technologies for Genomics-Guided Discovery of Natural Products
Current Topics in Medicinal Chemistry
Medicine
Drug Discovery
Rational Design of Bacitracin a Derivatives by Incorporating Natural Product Derived Heterocycles
A Study on Synthesis of Antifouling Natural Products and Their Derivatives
Sessile Organisms
De Novo Biosynthesis of 'Non-Natural' Thaxtomin Phytotoxins
Angewandte Chemie - International Edition
Catalysis
Chemistry
De Novo Design of Peptide Binding Antibodies
Biotechnology and Bioengineering
Applied Microbiology
Biotechnology
Bioengineering
De Novo Design of Synthetic Prion Domains
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Rational Design of Hybrid Natural Products by Utilizing the Promiscuity of an Amide Synthetase
